BuzzHere’s a polished English translation of the Chinese title: **”XtalPi Empowers Sigilon Therapeutics with Another IND: Potent pan-TEAD Inhibitor SIGX2649 Shows Strong Clinical Potential, AI + Organoid Model Continues to Be Validated”** Alternatively, a slightly more concise version: **”XtalPi Enables Sigilon’s New IND: Potent pan-TEAD Inhibitor SIGX2649 Highlights Clinical Promise, AI + Organoid Approach Gains Further Validation”**rocky TTJune 26, 2026
BuzzJingtai Technology’s Food-Grade Oral Peptide Tensotide™ Receives U.S. Self-GRAS Certification, AI-Designed Molecule Breaks into the Hundred-Billion-Dollar Metabolic Health Consumer Marketrocky TTJune 26, 2026
BuzzHere’s a polished English translation of the Chinese title: **”Bühler Bakery China 2026 Concludes: From Equipment Showcase to Full-Stage Empowerment”**rocky TTJune 26, 2026
BuzzIBM and Red Hat Commit $5 Billion to Redefine the Open Source Future in the AI Erarocky TTJune 26, 2026
BuzzShell Premium and American Hengzhou Technology Reach Strategic Cooperation, Fully Expanding into the Automotive Film Sectorrocky TTJune 26, 2026
BuzzSharp Reforms, Real Relief! At the Parent Luncheon of Huashi Xiping Bilingual School, Chairman Ke Xiping Delivers Six ‘Hardcore’ Answersrocky TTJune 26, 2026
BuzzHere’s a polished English translation of the Chinese title: **”Embracing Gen Z’s Slow Living Trend, the Polaroid Go 3rd Generation Pocket Instant Camera Arrives”**rocky TTJune 26, 2026
BuzzCloudbreak Newly announced an exclusive licensing and cooperation agreement for Xibutinib (EVER001).rocky TTJune 26, 2026
BuzzEMERALD-3 Phase III Trial: IMFINZI® Combined with IMJUDO®, Lenvatinib, and Transarterial Chemoembolization (TACE) Reduces Risk of Disease Progression or Death by 30% in Patients with Embolization-Eligible Unresectable Hepatocellular Carcinomarocky TTJune 26, 2026
